Scientific Programme

Abstracts accepted for oral and poster presentation will be published on the website scientific programme after the abstract submission deadline.

REGISTRATION & EXHIBITORS AREA OPENS

(COFFEE/TEA SERVED)

08.15-09.00

 

09.00-09.15 OPENING REMARKS

Professor Mike Dixon

 

SESSION 1 KEYNOTES: Endocrine Therapy Resistance (Chair: Prof Mike Dixon)

09.15-9.45 Professor Charles Perou - Quantitative medicine for ER-positive breast cancer patients

9.45-10.15 Professor Bob Clarke – A systems biology perspective of endocrine resistance

10.15-10.45 Professor Val Speirs – Identifying biomarkers of endocrine therapy resistance in breast cancer

10.45-11.00 Dr Arran Turnbull – A real-time genome-driven drug response approach for endocrine therapy resistant tumours

 

COFFEE/TEA BREAK & NETWORKING & EXHIBITORS AREA OPEN

11.15-11.45

 

SESSION 2 KEYNOTES: Novel Translational Biomarkers & Biomarker Discovery (Chair: Dr Olga Oikonomidou)

 

11.45-12.15 Professor John Bartlett – Novel approaches for biomarker discovery in breast cancer

 

12.15-12.35 Professor Ian Kunkler – Biomarker discovery for radiotherapy response

 

12.35-12.55 Dr Andrew Sims – The value of biomarkers in node positive disease

 

LUNCH & POSTER SESSION & NETWORKING & EXHIBITORS AREA OPEN

13.35-15.00

 

SESSION 3 KEYNOTES: Emerging Therapeutics (Chair: Dr Andrew Sims)

 

15.00-15.30 Professor Mitch Dowsett – Biomarker analyses in the presurgical setting to assist in drug development

 

15.30-15.50 Dr Olga Oikonomidou – Update on CDK4/6 inhibitors

 

15.50-16.10 Professor Val Brunton – Understanding the role of the tumour microenvironment in invasive lobular carcinoma

 

16.10-16.30 Professor David Cameron – Emerging oral SERDS and novel therapeutics

 

17.10-17.30 CLOSING REMARKS & PRIZE AWARDS

Professor J Michael Dixon

 

17.30 CONFERENCE ENDS